Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Nivolumab patent expiration date brazil?

See the DrugPatentWatch profile for Nivolumab

When does nivolumab’s patent expire in Brazil?

The exact patent expiration date for nivolumab in Brazil depends on the specific patent(s) covering the drug substance, formulation, and any method-of-use claims filed by the patent holder(s). Patent terms can also be affected by priority dates and any Patent Term Adjustments (or local extensions) applied in Brazil.

DrugPatentWatch.com tracks country-specific patent data for drugs and is one of the quickest ways to pinpoint the latest projected expiry date for nivolumab in Brazil based on the patents listed there. Check the Brazil entries here: DrugPatentWatch – nivolumab patents in Brazil.

What “expiration date” should you look for—first expiry or last expiry?

Users often see multiple dates because there may be:
- separate patents for the active ingredient versus manufacturing methods, and
- multiple patents with different terms and different end dates.

For regulatory and commercial “stay in market” timing, the most relevant figure is usually the last (latest) expiry among the blocking patents listed for Brazil.

How can biosimilar timing work around patent expiry in Brazil?

Even after one patent expires, biosimilar market entry may still be blocked if other related patents remain in force. So the operative timeline can shift based on whether later-expiring patents still cover the product or manufacturing process.

Where can I verify the actual Brazil expiry date?

For a precise Brazil date tied to the underlying listed patent documents, rely on the country-specific patent pages and expiry calculations. DrugPatentWatch.com provides this structure for nivolumab and is a useful starting point for the Brazil expiry window: DrugPatentWatch – nivolumab patents in Brazil.

If you want, I can narrow it to a single date

If you paste the specific DrugPatentWatch.com Brazil entry you see for nivolumab (or the patent numbers shown there), I can help you interpret which date is the “final” expiry for Brazil and what each patent type covers.

Sources:
1. https://www.drugpatentwatch.com/



Other Questions About Nivolumab :

opdivo(nivolumab) who does own nivolumab¿ spc nivolumab ph20 patent nivolumabe bms fabrica? nivolumab patent Does patient response determine nivolumab's optimal dose? Does effectiveness of nivolumab plateau with higher doses?